Condition

Acute Myeloid Leukemias clinical trials and research

• 2Clinical trials
• 23Countries

All recruiting trials (2)

• Revumenib plus intensive chemotherapy for newly diagnosed NPM1‑mutated acute myeloid leukemia

  This trial tests whether adding revumenib to standard intensive chemotherapy helps people newly diagnosed with NPM1‑mutated AML get better responses and live longer than chemotherapy alone.

  Recruiting at 173 sites Phase 3 Syndax Pharmaceuticals · Goodyear, Arizona and 172 other locations · NCT07211958

• Testing STX-0712 in patients with advanced blood cancers

  This study is testing a new drug called STX-0712 to see if it can help people with advanced blood cancers like chronic myelomonocytic leukemia and acute myeloid leukemia who have run out of other treatment options.

  Recruiting at 6 sites Phase 1 Solu Therapeutics, Inc · Stanford, California and 6 other locations · NCT06950034

Related topics

Quick answers

How many Acute Myeloid Leukemias clinical trials are recruiting right now?

2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 23 countries. The most sites are in United States (2 trials), Argentina (1 trial), Australia (1 trial), Austria (1 trial), Belgium (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 1: 1, Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →